Home › Parkinson's Disease › New Mexico › Albuquerque
Parkinson's Disease clinical trials in Albuquerque, NM
5 studies for Parkinson's Disease are looking for participants at sites in and around Albuquerque (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
RecruitingPhase 2
- University of New Mexico, Albuquerque
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
- Vima Site #014, Albuquerque
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
RecruitingPhase 2
- University of New Mexico Health Sciences Center (Site #225), Albuquerque
Parkinson's Foundation PD GENEration Genetic Registry
RecruitingObservational study
- University of New Mexico, Albuquerque
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
- University of New Mexico, Albuquerque
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY23 studies
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- New Haven, CT14 studies
- Farmington Hills, MI13 studies
- Charleston, SC13 studies
- Miami, FL13 studies
- Chicago, IL13 studies
Other studies in Albuquerque
- Non-Small Cell Lung Cancer18 studies
- Breast Cancer17 studies
- Ovarian Cancer15 studies
- Lung Cancer14 studies
- Cancer (all types)14 studies
- Endometrial Cancer12 studies
- Metastatic Cancer12 studies
- Type 2 Diabetes11 studies
- Cardiovascular Disease10 studies
- Prostate Cancer9 studies
- Melanoma9 studies
- Acute Myeloid Leukemia9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.